Using nanotechnology, UCF researchers have developed the first rapid detector for dopamine, a chemical that is believed to play a role in various diseases such as Parkinson’s, depression and some cancers.
Studies show too much dopamine could be associated with some cancers, while low dopamine could be associated with Parkinson’s disease and depression. The new technique developed at UCF requires only a few drops of blood, and results are available in minutes instead of hours because no separate lab is necessary to process the sample.
The new technology was described in a recent study in the journal Nano Letters.
More than half a million people in the United States have Parkinson’s and major episodes of depression affect about 16 million adults a year.
Current methods to detect dopamine are time consuming, require rigorous sample preparation, including blood-plasma separation, as well as specialized laboratory equipment. With this device, however, a few drops of blood on a palm-sized, rectangular chip is all that is needed.
“A neurotransmitter like dopamine is an important chemical to monitor for our overall well-being so we can help screen out neural disorders like Parkinson’s disease, various brain cancers, and monitor mental health,” said Debashis Chanda, an associate professor in UCF’s NanoScience Technology Center and the study’s principle investigator. “We need to monitor dopamine so that we can adjust our medical doses to help address those problems.”
Plasma is separated from the blood within the chip. Cerium oxide nanoparticles, which coat the sensor surface, selectively capture dopamine at microscopic levels from the plasma. The capture of dopamine molecules subsequently changes how light is reflected from the sensor and creates an optical readout indicating the level of dopamine.
Sudipta Seal, an engineering professor and chair of UCF’s Department of Materials Science and Engineering, said the use of cerium oxide nanoparticles was an important part of the sensor’s success.
“Getting the sensor to be sensitive to dopamine had been quite the challenge for researchers for a while, but using altered cerium oxide nanostructures on the sensing platform was key in making the sensor work,” Seal said.
Chanda co-developed the sensor with Abraham Vázquez-Guardado, a graduate of UCF’s College of Optics and Photonics and now a postdoctoral fellow at Northwestern University.
Vázquez-Guardado said reduced steps and processing make the test cost effective, and it can also be performed at the patient’s side rather than in a separate lab.
“There is no preprocessing needed,” he said. “Our plan was to make a much quicker, enzyme-free kind of detection.”
The Latest on: Dopamine sensor
via Google News
The Latest on: Dopamine sensor
- Controlling nerve cells with light opened new ways to study the brainon June 18, 2021 at 10:00 am
Cells of the algal species Chlamydomonas reinhardtii are decorated with proteins that can sense light. That ability, first noticed in 2002, quickly caught the attention of brain scientists. A ...
- New Approaches to Bedside Monitoring in Strokeon June 17, 2021 at 5:01 pm
One must also understand that flow can artifically increase with measures that increase cardiac output to treat VSP, such as use of vasopressors and dopamine. Such increases in systemic cardiac ...
- MRI Sensor Could Improve Brain Imagingon June 8, 2021 at 5:00 pm
Since the sensor responds to the chemicals involved in information processing in the brain, they can more precisely measure brain activity. Measuring dopamine in the brain could have potential for ...
- Drugs don’t make my Parkinson’s better — could a gadget help?on June 8, 2021 at 2:31 am
We decided on a course of Sinemet, the most common drug for replacing the missing dopamine in the brain ... to have remote monitoring by using a sensor that the patient can wear at home.” ...
- How AI is working with Parkinson’s patients?on June 4, 2021 at 11:11 am
There is medication to treat the symptoms but it is notoriously difficult to prescribe exactly the right dose of Sinemet and other drugs which act to replace the missing dopamine that makes ...
- Could Israel hold the key to solving the Parkinson’s puzzle?on June 1, 2021 at 7:01 am
By Abigail Klein Leichman It was in1917 that James Parkinson first described the syndrome now known as Parkinson’s disease ...
- Using Colonoscopy to Predict Parkinson’s Disease?on May 16, 2021 at 5:00 pm
Early diagnosis of Parkinson’s enables the disease to be treated with drugs such as dopamine agonists and monoamine oxidase type-B inhibitors, which can alleviate the condition’s symptoms and ...
- Mosquito Protein Lights Up Optogenetic Brain Studieson May 13, 2021 at 5:09 am
Unlike a conventional drug that affects numerous parts of the brain and is hard to control, the researchers found that since only neurons that produce the mosquito sensor are affected by the light ...
- Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s diseaseon May 5, 2021 at 5:00 pm
Increasing dopamine synthesis or α-synuclein amounts in mouse midbrain ... This increase was seen by using both a genetically encoded, mitochondrial matrix redox sensor (mito-roGFP) (5) and by ...
via Bing News